Robyn Rourick

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM We evaluated three immunoassay-based technologies and their biomarker kits, by determining precision, parallelism and detectability of analytes of interest. MATERIALS & METHODS We compared ultrasensitive assays for three biomarkers: interleukins IL-6, IL-13 and IL-17A using kits obtained from Roche (IMPACT platform - proprietary platform), Singulex(More)
  • 1